Biocon Profile
Key Indicators
- Authorised Capital ₹ 625.00 Cr
as on 07-07-2024
- Paid Up Capital ₹ 600.30 Cr
as on 07-07-2024
- Company Age 45 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1,777.63 Cr
as on 07-07-2024
- Satisfied Charges ₹ 440.35 Cr
as on 07-07-2024
- Revenue 17.60%
(FY 2023)
- Profit 3208.25%
(FY 2023)
- Ebitda -61.54%
(FY 2023)
- Net Worth 34.88%
(FY 2023)
- Total Assets 46.92%
(FY 2023)
About Biocon
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532523 and on the National Stock Exchange(NSE) under BIOCON.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 625.00 Cr and a paid-up capital of Rs 600.30 Cr.
The company currently has active open charges totaling ₹1,777.63 Cr. The company has closed loans amounting to ₹440.35 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biocon Limited India are Siddharth Mittal as CEO and Mayank Verma as Company Secretary. Naina Kidwai, Bobby Parikh, Ravi Mazumdar, and Six other members serve as directors at the Company.
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Biocon?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddharth Mittal  | Managing Director | 01-Dec-2019 | Current |
| Mayank Verma | Company Secretary | 25-Jul-2019 | Current |
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rekha Menon | Director | 26-Jul-2023 | Current |
| Naina Kidwai | Director | 28-Apr-2022 | Current |
| Meleveetil Damodaran | Director | 26-Apr-2016 | Current |
| Kiran Shaw | Director | 01-Apr-2010 | Current |
| Bobby Parikh | Director | 27-Jul-2018 | Current |
Ravi Mazumdar  | Director | 08-Aug-2000 | Current |
Financial Performance and Corporate Structure Insights of Biocon.
Biocon Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.6% increase. The company also saw a substantial improvement in profitability, with a 3208.25% increase in profit. The company's net worth Soared by an impressive increase of 34.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biocon?
In 2022, Biocon had a promoter holding of 60.63% and a public holding of 39.37%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Apr 2023 | ₹500.00 Cr | Open |
Others Creation Date: 12 Feb 2023 | ₹1,070.00 Cr | Open |
Hdfc Bank Limited Creation Date: 07 Nov 2022 | ₹197.50 Cr | Open |
How Many Employees Work at Biocon?
Biocon has a workforce of 4020 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biocon, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biocon's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
